Table 2.
Logistic remission analyses examining the effect of sex on the study outcomes.
| Outcomes at 6 Months | Female, n (%) |
Male, n (%) |
OR for Female [95% CI] |
p-Value | ORadj for Female [95% CI] |
p-Value |
|---|---|---|---|---|---|---|
| DAS28-ESR remission | 23 (18.0) | 9 (40.9) | 0.32 [0.12–0.83] | 0.019 | 0.30 [0.11–0.81] | 0.018 |
| DAS28-ESR LDA | 42 (32.8) | 13 (59.1) | 0.34 [0.13–0.85] | 0.022 | 0.34 [0.13–0.86] | 0.023 |
| DAS28-CRP remission | 44 (34.4) | 11 (50.0) | 0.52 [0.21–1.30] | 0.165 | 0.52 [0.20–1.32] | 0.169 |
| DAS28-CRP LDA | 61 (47.7) | 13 (59.1) | 0.63 [0.25–1.58] | 0.324 | 0.61 [0.24–1.58] | 0.309 |
| CDAI remission | 9 (7.0) | 3 (13.6) | 0.48 [0.12–1.93] | 0.301 | 0.47 [0.11–1.98] | 0.305 |
| CDAI LDA | 67 (52.3) | 14 (63.6) | 0.63 [0.25–1.60] | 0.329 | 0.58 [0.22–1.58] | 0.289 |
| SDAI remission | 20 (15.6) | 6 (27.3) | 0.49 [0.17–1.41] | 0.189 | 0.54 [0.18–1.62] | 0.273 |
| SDAI LDA | 68 (53.1) | 13 (59.1) | 0.78 [0.31–1.97] | 0.605 | 0.74 [0.28–1.95] | 0.546 |
OR—odds ratio, CI—confidence interval, ORadj—odds ratio adjusted, DAS28-ESR—Disease Activity Score 28-joint count using Erythrocyte Sedimentation Rate, LDA—low disease activity, DAS28-CRP—Disease Activity Score 28-joint count using C-Reactive Protein, CDAI—Clinical Disease Activity Index, SDAI—Simplified Disease Activity Index.